Document is current
Any future updates will be listed below
-
Authors
Fiala, Ondřej
Buti, Sebastiano
Takeshita, Hideki
Okada, Yohei
Massari, Francesco
Palacios, Georgia Anguera
Dionese, Michele
Scagliarini, Sarah
Büttner, Thomas
Fornarini, Giuseppe
Myint, Zin W.
Galli, Luca
Souza, Vinicius Carrera
Pichler, Renate
De Giorgi, Ugo
Quiroga, María Natalia Gandur
Gilbert, Danielle
Popovic, Lazar
Grande, Enrique
Mammone, Giulia
Berardi, Rossana
Crabb, Simon J.
Molina-Cerrillo, Javier
Freitas, Marcelo
Luz, Murilo
Iacovelli, Roberto
Calabrò, Fabio
Tural, Deniz
Atzori, Francesco
Küronya, Zsófia
Chiari, Rita
Campos, Saul
Caffo, Orazio
Fay, André P.
Kucharz, Jakub
Zucali, Paolo Andrea
Rinck, José Augusto
Zeppellini, Annalisa
Bastos, Diogo Assed
Aurilio, Gaetano
Mota, Augusto
Trindade, Karine
Ortega, Cinzia
Sade, Juan Pablo
Rizzo, Mimma
Vau, Nuno
Giannatempo, Patrizia
Barillas, Allan
Monteiro, Fernando Sabino Marques
Dauster, Breno
Cattrini, Carlo
Nogueira, Lucas
de Carvalho Fernandes, Roni
Seront, Emmanuel
Aceituno, Luís Garcia
Grillone, Francesco
Cutuli, Hernan Javier
Fernandez, Mauricio
Bassanelli, Maria
Roviello, Giandomenico
Abahssain, Halima
Procopio, Giuseppe
Milella, Michele
Kopecky, Jindrich
Martignetti, Angelo
Messina, Carlo
Caitano, Manuel
Inman, Eva
Kanesvaran, Ravindran
Herchenhorn, Daniel
Santini, Daniele
Manneh, Ray
Bisonni, Renato
Zakopoulou, Roubini
Mosca, Alessandra
Morelli, Franco
Maluf, Fernando
Soares, Andrey
Nunes, Fernando
Pinto, Alvaro
Zgura, Anca
Incorvaia, Lorena
Ansari, Jawaher
Zabalza, Ignacio Ortego
Landmesser, Johannes
Rizzo, Alessandro
Mollica, Veronica
Sorgentoni, Giulia
Battelli, Nicola
Porta, Camillo
Bellmunt, Joaquim
Santoni, Matteo
- License Information
-
More Information
Article History
Received: 4 May 2023
Accepted: 3 August 2023
First Online: 7 September 2023
Declarations
:
: O. Fiala received honoraria from Roche, Janssen, GSK and Pfizer for consultations and lectures unrelated to this project. S. Buti received honoraria as speaker at scientific events and advisory role by BMS, Pfizer, MSD, Ipsen, AstraZeneca, Merck, all unrelated to this project. M. Santoni has received research support and honoraria from Janssen, Bristol Myers Squibb, Ipsen, MSD, Astellas and Bayer, all unrelated to this project. R. Kanesvaran has received fees for speaker bureau and advisory board activities from the following companies; Pfizer, MSD, BMS, Eisai, Ipsen, Johnson and Johnson, Merck, Amgen, Astellas and Bayer, all unrelated to this project. E. Grande has received honoraria for speaker engagements, advisory roles or funding of continuous medical education from Adacap, AMGEN, Angelini, Astellas, Astra Zeneca, Bayer, Blueprint, Bristol Myers Squibb, Caris Life Sciences, Celgene, Clovis-Oncology, Eisai, Eusa Pharma, Genetracer, Guardant Health, HRA-Pharma, IPSEN, ITM-Radiopharma, Janssen, Lexicon, Lilly, Merck KGaA, MSD, Nanostring Technologies, Natera, Novartis, ONCODNA (Biosequence), Palex, Pharmamar, Pierre Fabre, Pfizer, Roche, Sanofi-Genzyme, Servier, Taiho, and Thermo Fisher Scientific and has received research grants from Pfizer, Astra Zeneca, Astellas, and Lexicon Pharmaceuticals, all unrelated to this project. F. S. M. Monteiro has received research support from Janssen, Merck Sharp Dome and honoraria from Janssen, Ipsen, Bristol Myers Squibb and Merck Sharp Dome, all unrelated to this project. C. Porta has received honoraria from Angelini Pharma, Astra Zeneca, BMS, Eisai, General Electric, Ipsen and MSD and acted as a Protocol Steering Committee Member for BMS, Eisai and MSD, all unrelated to this project. Z. Myint has received research support from Merck unrelated to this project. J. Molina-Cerrillo declares consultant, advisory or speaker roles for IPSEN, Roche, Pfizer, Sanofi, Janssen, and BMS and has received research grants from Pfizer, IPSEN and Roche, all unrelated to this project. P. Giannatempo has received research support from Ipsen, Astra Zeneca, MSD and honoraria for speaker engagements, advisory roles from Astellas, MSD, Janssen, Pfizer, all unrelated to this project. E. T. Lam has received institutional research funding from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, Bristol-Myers Squibb, Pfizer, and F. Hoffmann-La Roche Ltd. The other authors declare to have no conflicts of interest.
